Published online before print April 15, 2002, doi: 10.1161/01.CIR.0000015075.89984.46
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2002;105:1949.)
© 2002 American Heart Association, Inc.
Clinical Investigation and Reports |
Human Leukocyte Antigen-G Expression After Heart Transplantation Is Associated With a Reduced Incidence of Rejection
From the Laboratory for the Study of Cardiac Grafts and Prostheses, University of Pierre et Marie Curie, Broussais Hospital (N.L., A.C.); the Department of Cardiovascular Surgery and Organ Transplantation, Georges Pompidou Hospital (C.A., R.G., P.C., C.L., J.-N.F., A.C.); and Research Institute for Hemato-Immunology, CEA Laboratory, Saint-Louis Hospital (J.D., E.D.C.), Paris, France.
Correspondence to Nermine Lila, DVM, Laboratory for the Study of Cardiac Grafts and Prostheses, University of Pierre et Marie Curie, Broussais Hospital, 96 rue Didot 75014 Paris, France. E-mail nerminelila{at}yahoo.fr
Background— Human leukocyte antigen (HLA)-G, a nonclassic major histocompatibility complex class I molecule expressed in the extravillous cytotrophoblast at the feto-maternal interface, is known to protect the fetus from maternal cellular immunity. In a preliminary study, we showed that HLA-G is expressed in the hearts of some patients after heart transplantation.
Methods and Results— In the present study, a larger number of patients was investigated to confirm this finding and to look for possible correlations between HLA-G expression and the number and types of rejection. Expression of HLA-G in endomyocardial biopsy specimens was investigated by immunohistochemical analysis, and detection of the soluble HLA-G in the serum was performed by immunoprecipitation followed by Western blot analysis. HLA-G was detected in the biopsy specimens and serum of 9 of 51 patients (18%). The number of episodes of acute rejection was significantly lower in HLA-G-positive patients (1.2±1.1) as compared with HLA-G-negative patients (4.5±2.8) (P<0.001). No chronic rejection was observed in HLA-G-positive patients, whereas 15 HLA-G-negative patients had chronic rejection (P<0.032). A longitudinal study of these patients reveals that the status of HLA-G expression was maintained after 6 months both in serum and in biopsy specimens. During this period, HLA-G-positive patients did not have chronic rejection.
Conclusions— There is a significant correlation between rejection and HLA-G expression in the heart after transplantation. HLA-G expression and its effect in reducing the incidence and severity of rejection seem to be stable throughout the evolution.
Key Words: transplantation • genes • rejection • grafting
This article has been cited by other articles:
 |
|
 |
|
  R. Sheshgiri, V. Rao, L. C. Tumiati, R. Xiao, J. L. Prodger, M. Badiwala, C. Librach, and D. H. Delgado Progesterone Induces Human Leukocyte Antigen-G Expression in Vascular Endothelial and Smooth Muscle Cells Circulation, September 30, 2008; 118(14_suppl_1): S58 - S64. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. D. Carosella, B. Favier, N. Rouas-Freiss, P. Moreau, and J. LeMaoult Beyond the increasing complexity of the immunomodulatory HLA-G molecule Blood, May 15, 2008; 111(10): 4862 - 4870. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Naji, S. Le Rond, A. Durrbach, I. Krawice-Radanne, C. Creput, M. Daouya, J. Caumartin, J. LeMaoult, E. D. Carosella, and N. Rouas-Freiss CD3+CD4low and CD3+CD8low are induced by HLA-G: novel human peripheral blood suppressor T-cell subsets involved in transplant acceptance Blood, December 1, 2007; 110(12): 3936 - 3948. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Feger, E. Tolosa, Y.-H. Huang, A. Waschbisch, T. Biedermann, A. Melms, and H. Wiendl HLA-G expression defines a novel regulatory T-cell subset present in human peripheral blood and sites of inflammation Blood, July 15, 2007; 110(2): 568 - 577. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. V. F. Hviid HLA-G in human reproduction: aspects of genetics, function and pregnancy complications Hum. Reprod. Update, May 1, 2006; 12(3): 209 - 232. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Le Rond, C. Azema, I. Krawice-Radanne, A. Durrbach, C. Guettier, E. D. Carosella, and N. Rouas-Freiss Evidence to Support the Role of HLA-G5 in Allograft Acceptance through Induction of Immunosuppressive/ Regulatory T Cells. J. Immunol., March 1, 2006; 176(5): 3266 - 3276. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Bahri, F. Hirsch, A. Josse, N. Rouas-Freiss, N. Bidere, A. Vasquez, E. D. Carosella, B. Charpentier, and A. Durrbach Soluble HLA-G Inhibits Cell Cycle Progression in Human Alloreactive T Lymphocytes J. Immunol., February 1, 2006; 176(3): 1331 - 1339. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Rouas-Freiss, P. Moreau, S. Ferrone, and E. D. Carosella HLA-G Proteins in Cancer: Do They Provide Tumor Cells with an Escape Mechanism? Cancer Res., November 15, 2005; 65(22): 10139 - 10144. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Wiendl, U. Feger, M. Mittelbronn, C. Jack, B. Schreiner, C. Stadelmann, J. Antel, W. Brueck, R. Meyermann, A. Bar-Or, et al. Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity Brain, November 1, 2005; 128(11): 2689 - 2704. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Blaschitz, H. Juch, A. Volz, H. Hutter, C. Daxboeck, G. Desoye, and G. Dohr The soluble pool of HLA-G produced by human trophoblasts does not include detectable levels of the intron 4-containing HLA-G5 and HLA-G6 isoforms Mol. Hum. Reprod., October 1, 2005; 11(10): 699 - 710. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. LeMaoult, N. Rouas-Freiss, and E. D. Carosella HLA-G5 expression by trophoblast cells: the facts Mol. Hum. Reprod., October 1, 2005; 11(10): 719 - 722. [Full Text] [PDF]
|
|
|
|
 |
|
 J. S. Hunt, M. G. Petroff, R. H. McIntire, and C. Ober HLA-G and immune tolerance in pregnancy FASEB J, May 1, 2005; 19(7): 681 - 693. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Noci, B. Fuzzi, R. Rizzo, L. Melchiorri, L. Criscuoli, S. Dabizzi, R. Biagiotti, S. Pellegrini, A. Menicucci, and O.R. Baricordi Embryonic soluble HLA-G as a marker of developmental potential in embryos Hum. Reprod., January 1, 2005; 20(1): 138 - 146. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Le Friec, F. Gros, Y. Sebti, V. Guilloux, C. Pangault, R. Fauchet, and L. Amiot Capacity of myeloid and plasmacytoid dendritic cells especially at mature stage to express and secrete HLA-G molecules J. Leukoc. Biol., December 1, 2004; 76(6): 1125 - 1133. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. Hodgson, A. Behfar, L. V. Zingman, G. C. Kane, C. Perez-Terzic, A. E. Alekseev, M. Puceat, and A. Terzic Stable benefit of embryonic stem cell therapy in myocardial infarction Am J Physiol Heart Circ Physiol, August 1, 2004; 287(2): H471 - H479. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. LeMaoult, I. Krawice-Radanne, J. Dausset, and E. D. Carosella HLA-G1-expressing antigen-presenting cells induce immunosuppressive CD4+ T cells PNAS, May 4, 2004; 101(18): 7064 - 7069. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. Morales, J. L. Pace, J. S. Platt, T. A. Phillips, K. Morgan, A. T. Fazleabas, and J. S. Hunt Placental Cell Expression of HLA-G2 Isoforms Is Limited to the Invasive Trophoblast Phenotype J. Immunol., December 1, 2003; 171(11): 6215 - 6224. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E H Kemp, R A Metcalfe, P F Watson, and A P Weetman HLA-G does not have a pathophysiological role in Graves' disease J. Clin. Pathol., June 1, 2003; 56(6): 475 - 477. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Moreau, G. Mouillot, P. Rousseau, C. Marcou, J. Dausset, and E. D. Carosella HLA-G gene repression is reversed by demethylation PNAS, February 4, 2003; 100(3): 1191 - 1196. [Abstract] [Full Text] [PDF]
|
|